{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:32:20Z","timestamp":1694629940289},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/s11920-004-0011-2","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T05:06:58Z","timestamp":1181365618000},"page":"459-465","source":"Crossref","is-referenced-by-count":4,"title":["Separate and concomitant use of lamotrigine, lithium, and divalproex in bipolar disorders"],"prefix":"10.1007","volume":"6","author":[{"given":"Daniel Z.","family":"Lieberman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick K.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4088\/JCP.v64n0111","volume":"64","author":"RM Hirschfeld","year":"2003","unstructured":"Hirschfeld RM, Calabrese JR, Weissman MM, et al.: Screening for bipolar disorder in the community. J Clin Psychiatry 2003, 64:53\u201359.","journal-title":"J Clin Psychiatry"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4088\/JCP.v64n0209","volume":"64","author":"RM Hirschfeld","year":"2003","unstructured":"Hirschfeld RM, Lewis L, Vornik LA: Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 2003, 64:161\u2013174.","journal-title":"J Clin Psychiatry"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4088\/PCC.v05n0402","volume":"5","author":"PA Pirraglia","year":"2003","unstructured":"Pirraglia PA, Stafford RS, Singer DE: Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care. Prim Care Companion J Clin Psychiatry 2003, 5:153\u2013157.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0165-0327(01)00355-X","volume":"73","author":"PE Keck Jr","year":"2003","unstructured":"Keck Jr PE, McElroy SL: Redefining mood stabilization. J Affect Disord 2003, 73:163\u2013169.","journal-title":"J Affect Disord"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1176\/appi.ajp.161.1.3","volume":"161","author":"MS Bauer","year":"2004","unstructured":"Bauer MS, Mitchner L: What is a \u201cmood stabilizer\u201d? An evidence-based response. Am J Psychiatry 2004, 161:3\u201318.","journal-title":"Am J Psychiatry"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0006-2952(03)00187-4","volume":"66","author":"AJ Harwood","year":"2003","unstructured":"Harwood AJ, Agam G: Search for a common mechanism of mood stabilizers. Biochem Pharmacol 2003, 66:179\u2013189.","journal-title":"Biochem Pharmacol"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1046\/j.1471-4159.2003.01869.x","volume":"85","author":"H Son","year":"2003","unstructured":"Son H, Yu IT, Hwang SJ, et al.: Lithium enhances long-term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus. J Neurochem 2003, 85:872\u2013881.","journal-title":"J Neurochem"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1046\/j.1471-4159.2004.02329.x","volume":"89","author":"JS Kim","year":"2004","unstructured":"Kim JS, Chang MY, Yu IT, et al.: Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo. J Neurochem 2004, 89:324\u2013336.","journal-title":"J Neurochem"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00004850-200303000-00002","volume":"18","author":"PH Silverstone","year":"2003","unstructured":"Silverstone PH, Wu RH, O\u2019Donnell T, et al.: Chronic treatment with lithium, but not sodium valproate, increases cortical Nacetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol 2003, 18:73\u201379. Chronic treatment with lithium has been shown to increase NAA concentrations, which may be a good marker for neuronal viability and\/or functioning. Using H magnetic resonance spectroscopy, the authors quantified NAA concentrations in patients treated with lithium or divalproex, and in healthy control subjects.","journal-title":"Int Clin Psychopharmacol"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/sj.npp.1300283","volume":"29","author":"TD Gould","year":"2004","unstructured":"Gould TD, Chen G, Manji HK: In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 2004, 29:32\u201338.","journal-title":"Neuropsychopharmacology"},{"issue":"suppl 3","key":"11_CR11","first-page":"S250","volume":"36","author":"M Bauer","year":"2003","unstructured":"Bauer M, Alda M, Priller J, Young LT: Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Pharmacopsychiatry 2003, 36(suppl 3):S250-S254.","journal-title":"Pharmacopsychiatry"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S1461145703003419","volume":"6","author":"N Brunello","year":"2003","unstructured":"Brunello N, Tascedda F: Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders. Int J Neuropsychopharmacol 2003, 6:181\u2013189.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"suppl 2","key":"11_CR13","first-page":"17","volume":"37","author":"MJ Owens","year":"2003","unstructured":"Owens MJ, Nemeroff CB: Pharmacology of valproate. Psychopharmacol Bull 2003, 37(suppl 2):17\u201324.","journal-title":"Psychopharmacol Bull"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0278-5846(03)00028-9","volume":"27","author":"IS Shiah","year":"2003","unstructured":"Shiah IS, Yatham LN, Gau YC, Baker GB: Effect of lamotrigine on plasma GABA levels in healthy humans. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:419\u2013423.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/01.jcp.0000088915.02635.e8","volume":"23","author":"TA Ketter","year":"2003","unstructured":"Ketter TA, Manji HK, Post RM: Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. J Clin Psychopharmacol 2003, 23:484\u2013495.","journal-title":"J Clin Psychopharmacol"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2165\/00003495-200363190-00009","volume":"63","author":"DR Goldsmith","year":"2003","unstructured":"Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM: Lamotrigine: a review of its use in bipolar disorder. Drugs 2003, 63:2029\u20132050.","journal-title":"Drugs"},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.4088\/JCP.v64n0717","volume":"64","author":"RM Hirschfeld","year":"2003","unstructured":"Hirschfeld RM, Baker JD, Wozniak P, et al.: The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder. J Clin Psychiatry 2003, 64:841\u2013846.","journal-title":"J Clin Psychiatry"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000070015","volume":"47","author":"K Jagadheesan","year":"2003","unstructured":"Jagadheesan K, Duggal HS, Gupta SC, et al.: Acute antimanic efficacy and safety of intravenous valproate loading therapy: an open-label study. Neuropsychobiology 2003, 47:90\u201393.","journal-title":"Neuropsychobiology"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4088\/JCP.v65n0111","volume":"65","author":"K Phrolov","year":"2004","unstructured":"Phrolov K, Applebaum J, Levine J, et al.: Single-dose intravenous valproate in acute mania. J Clin Psychiatry 2004, 65:68\u201370.","journal-title":"J Clin Psychiatry"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1034\/j.1399-5618.2003.00019.x","volume":"5","author":"LN Yatham","year":"2003","unstructured":"Yatham LN, Calabrese JR, Kusumakar V: Bipolar depression: criteria for treatment selection, definition of refractoriness, and treatment options. Bipolar Disord 2003, 5:85\u201397.","journal-title":"Bipolar Disord"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4088\/JCP.v65n1109","volume":"65","author":"JR Calabrese","year":"2004","unstructured":"Calabrese JR, Kasper S, Johnson G, et al.: International Consensus Group on Bipolar I Depression Treatment Guidelines. J Clin Psychiatry 2004, 65:571\u2013579.","journal-title":"J Clin Psychiatry"},{"key":"11_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/S1461145703003341","volume":"6","author":"LL Judd","year":"2003","unstructured":"Judd LL, Schettler PJ, Akiskal HS, et al.: Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmacol 2003, 6:127\u2013137.","journal-title":"Int J Neuropsychopharmacol"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","volume":"60","author":"CL Bowden","year":"2003","unstructured":"Bowden CL, Calabrese JR, Sachs G, et al.: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003, 60:392\u2013400.","journal-title":"Arch Gen Psychiatry"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","volume":"64","author":"JR Calabrese","year":"2003","unstructured":"Calabrese JR, Bowden CL, Sachs G, et al.: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003, 64:1013\u20131024.","journal-title":"J Clin Psychiatry"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4088\/JCP.v65n0321","volume":"65","author":"GM Goodwin","year":"2004","unstructured":"Goodwin GM, Bowden CL, Calabrese JR, et al.: A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004, 65:432\u2013441. This study, one of the largest to investigate the maintenance phase of bipolar disorder, compared lithium and lamotrigine monotherapies to placebo. The time to intervention was greater than placebo for patients taking lithium and lamotrigine. Lithium showed particular efficacy in delaying time to intervention for manic symptoms, and lamotrigine worked similarly for depressive symptoms.","journal-title":"J Clin Psychiatry"},{"key":"11_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4088\/JCP.v65n0210","volume":"65","author":"SL McElroy","year":"2004","unstructured":"McElroy SL, Zarate CA, Cookson J, et al.: A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression. J Clin Psychiatry 2004, 65:204\u2013210.","journal-title":"J Clin Psychiatry"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4088\/JCP.v60n0203","volume":"60","author":"JR Calabrese","year":"1999","unstructured":"Calabrese JR, Bowden CL, Sachs GS, et al.: A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999, 60:79\u201388.","journal-title":"J Clin Psychiatry"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/sj.npp.1300190","volume":"28","author":"L Gyulai","year":"2003","unstructured":"Gyulai L, Bowden CL, McElroy SL, et al.: Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology 2003, 28:1374\u20131382.","journal-title":"Neuropsychopharmacology"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1176\/appi.ajp.159.7.1155","volume":"159","author":"RH Perlis","year":"2002","unstructured":"Perlis RH, Sachs GS, Lafer B, et al.: Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry 2002, 159:1155\u20131159.","journal-title":"Am J Psychiatry"},{"key":"11_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1600-0447.2003.00274.x","volume":"109","author":"J Cavanagh","year":"2004","unstructured":"Cavanagh J, Smyth R, Goodwin GM: Relapse into mania or depression following lithium discontinuation: a 7-year follow-up. Acta Psychiatr Scand 2004, 109:91\u201395.","journal-title":"Acta Psychiatr Scand"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1034\/j.1399-5618.1999.10106.x","volume":"1","author":"RJ Baldessarini","year":"1999","unstructured":"Baldessarini RJ, Tondo L, Viguera AC: Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord 1999, 1:17\u201324.","journal-title":"Bipolar Disord"},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0165-0327(03)00133-2","volume":"80","author":"O Yazici","year":"2004","unstructured":"Yazici O, Kora K, Polat A, Saylan M: Controlled lithium discontinuation in bipolar patients with good response to longterm lithium prophylaxis. J Affect Disord 2004, 80:269\u2013271. The risk of recurrence after lithium discontinuation is high even in patients who have been stable for many years. A gradual discontinuation protocol, as opposed to abrupt discontinuation, may reduce early relapse. However, during a period of 1 to 12 months, most patients in this study experienced a recurrence.","journal-title":"J Affect Disord"},{"key":"11_CR33","doi-asserted-by":"crossref","unstructured":"Calabrese JR, Shelton MD, Rapport DJ, et al.: Current research on rapid cycling bipolar disorder and its treatment. J Affect Disord 200, 67:241\u2013255.","DOI":"10.1016\/S0165-0327(98)00161-X"},{"key":"11_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1034\/j.1600-0447.2003.00126.x","volume":"108","author":"L Tondo","year":"2003","unstructured":"Tondo L, Hennen J, Baldessarini RJ: Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand 2003, 108:4\u201314.","journal-title":"Acta Psychiatr Scand"},{"issue":"suppl B","key":"11_CR35","first-page":"9","volume":"51","author":"K Rickels","year":"1990","unstructured":"Rickels K, Schweizer E: Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry 1990, 51(suppl B):9\u201312.","journal-title":"J Clin Psychiatry"},{"issue":"suppl 5","key":"11_CR36","first-page":"53","volume":"64","author":"P Grof","year":"2003","unstructured":"Grof P: Selecting effective long-term treatment for bipolar patients: monotherapy and combinations. J Clin Psychiatry 2003, 64(suppl 5):53\u201361.","journal-title":"J Clin Psychiatry"},{"key":"11_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1034\/j.1399-5618.2003.00026.x","volume":"5","author":"MJ Passmore","year":"2003","unstructured":"Passmore MJ, Garnham J, Duffy A, et al.: Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord 2003, 5:110\u2013114. Patients who were responsive to lithium or lamotrigine were evaluated based on clinical characteristics and family history of mental illness. Patients who responded to lithium had a clearly distinct profile compared with lamotrigine responders, suggesting that it may be possible to predict which medication would be most likely to be effective for a specific patient.","journal-title":"Bipolar Disord"},{"key":"11_CR38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/hrp.11.5.245.256","volume":"11","author":"IM Bratti","year":"2003","unstructured":"Bratti IM, Baldessarini RJ, Baethge C, Tondo L: Pretreatment episode count and response to lithium treatment in manicdepressive illness. Harv Rev Psychiatry 2003, 11:245\u2013256.","journal-title":"Harv Rev Psychiatry"},{"issue":"suppl 5","key":"11_CR39","first-page":"18","volume":"64","author":"FK Goodwin","year":"2003","unstructured":"Goodwin FK: Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. J Clin Psychiatry 2003, 64(suppl 5):18\u201324.","journal-title":"J Clin Psychiatry"},{"key":"11_CR40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1034\/j.1399-5618.2003.00034.x","volume":"5","author":"CA Zarate Jr","year":"2003","unstructured":"Zarate Jr CA, Quiroz JA: Combination treatment in bipolar disorder: a review of controlled trials. Bipolar Disord 2003, 5:217\u2013225.","journal-title":"Bipolar Disord"},{"key":"11_CR41","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1001\/jama.290.11.1467","volume":"290","author":"FK Goodwin","year":"2003","unstructured":"Goodwin FK, Fireman B, Simon GE, et al.: Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003, 290:1467\u20131473. Suicide is a major public health problem, and there is a pressing need to identify treatments that effectively reduce the risk. A retrospective cohort study done at two large integrated health plans found that among patients with a diagnosis of bipolar disorder, the risk of suicide death was 2.7 times higher during treatment with divalproex than during treatment with lithium.","journal-title":"JAMA"},{"key":"11_CR42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/01.jcp.0000125745.60149.c6","volume":"24","author":"N Rasgon","year":"2004","unstructured":"Rasgon N: The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence. J Clin Psychopharmacol 2004, 24:322\u2013334.","journal-title":"J Clin Psychopharmacol"},{"key":"11_CR43","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1467-8624.2004.00727.x","volume":"75","author":"BR Van den Bergh","year":"2004","unstructured":"Van den Bergh BR, Marcoen A: High antenatal maternal anxiety is related to ADHD symptoms, externalizing problems, and anxiety in 8- and 9-year-olds. Child Dev 2004, 75:1085\u20131097.","journal-title":"Child Dev"},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1176\/appi.ajp.161.4.608","volume":"161","author":"KA Yonkers","year":"2004","unstructured":"Yonkers KA, Wisner KL, Stowe Z, et al.: Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004, 161:608\u2013620.","journal-title":"Am J Psychiatry"},{"key":"11_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1034\/j.1600-0404.2003.00200.x","volume":"109","author":"A Sabers","year":"2004","unstructured":"Sabers A, Dam M, B AR-H, et al.: Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol Scand 2004, 109:9\u201313.","journal-title":"Acta Neurol Scand"},{"key":"11_CR46","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, et al.: Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995, 333:1600\u20131607.","journal-title":"N Engl J Med"},{"key":"11_CR47","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1017\/S0317167100034910","volume":"25","author":"JA Messenheimer","year":"1998","unstructured":"Messenheimer JA: Rash in adult and pediatric patients treated with lamotrigine. Can J Neurol Sci 1998, 25:S14\u20138.","journal-title":"Can J Neurol Sci"},{"key":"11_CR48","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","volume":"49","author":"B Rzany","year":"1996","unstructured":"Rzany B, Mockenhaupt M, Baur S, et al.: Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990\u20131992): structure and results of a population-based registry. J Clin Epidemiol 1996, 49:769\u2013773.","journal-title":"J Clin Epidemiol"},{"key":"11_CR49","unstructured":"Massengill HS, Kustra KP, Messenheimer JA: Serious cutaneous reactions with antiepileptic drugs: adult and pediatric incidence estimates from registry and prescription data in Germany. Presented at American Society of Health Systems Pharmacists Midyear Meeting. New Orleans, LA, 2003."},{"key":"11_CR50","volume-title":"The global burden of disease and injury series, volume 1: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020","author":"CJL Murray","year":"1996","unstructured":"Murray CJL, Lopez AD: The global burden of disease and injury series, volume 1: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA, Harvard University Press, 1996."}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0011-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-004-0011-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0011-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0011-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T12:25:01Z","timestamp":1652617501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-004-0011-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s11920-004-0011-2","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}